Answer
Aug 08, 2025 - 10:15 AM
DUPIXENT (dupilumab) is a long-term treatment option for conditions like atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis. The duration of treatment with DUPIXENT is generally determined by a healthcare provider based on the individual's response to the medication and the specific condition being treated. Patients can remain on DUPIXENT as long as they continue to benefit from it and do not experience any adverse effects, under the guidance of their healthcare provider.
